Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01287871 · ClinicalTrials.gov registry record · NA

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

A NA study of Cervical Cancer Screening, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
336
Enrollment target
1
Study location

NCT01287871: Active NA study of Cervical Cancer Screening, sponsored by City of Hope Medical Center.

NCT01287871 is a NA study of Cervical Cancer Screening that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 336 participants, above the 275-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01287871, a NA study of Cervical Cancer Screening, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
336 participants
Enrollment target
1
Study location

Study Summary

This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical cancer stigma from a culturally relevant theoretical and conceptual framework; and 3) assess the influence of stigma on hindering seeking the PAP test. Further, this is an international study that will bring together a multi-disciplinary investigatory team, community advocates and State health agencies to deliver a social marketing intervention in Southern California (the Inland Empire region specifically) and Trinidad and Tobago.

Primary Outcome

To evaluate the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer, by determining whether, among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline, degree of exposure to the intervention is associated with the following endpoints at 3 months after the intervention is implemented: 1. post-intervention change in stigma score relative to pre-intervention, and 2. Pap testing (scored as 0=made no

Conditions Studied

Interventions

  • OTHER supportive care

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 336 participants
Start Date 2011-01
Est. Completion 2025-12-31
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT01287871 still lists

NCT01287871 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, above the 275-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Cervical Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which supportive care is the first listed.

NCT01287871 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01287871 about?

NCT01287871 is a clinical study titled "Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer". This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical ca...

What is the current status of trial NCT01287871?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 336 participants. The study started on 2011-01. Estimated completion is 2025-12-31.

What conditions does trial NCT01287871 study?

This clinical trial studies the following conditions: Cervical Cancer Screening.

What interventions are being tested in trial NCT01287871?

The interventions under investigation include: supportive care (OTHER).

Who is sponsoring clinical trial NCT01287871?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01287871 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03947385 · 336 participants · Phase 1

    Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • NCT03977207 · 336 participants · NA

    A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

  • NCT04665206 · 336 participants · Phase 1

    Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  • NCT05124457 · 336 participants · Phase 2

    DETERMINE: Detemir vs NPH

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01287871, the US trial registry maintained by the National Library of Medicine. NCT01287871 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.